Expanding Product Portfolio Inovet offers a comprehensive range of over 220 veterinary pharmaceutical products, including antibiotics, chemotherapeutics, vitamins, and anti-parasitic agents, providing multiple opportunities to cross-sell complementary products to veterinary clinics and animal health providers.

Global Market Presence With divisions across Europe and Vietnam, and worldwide activity, Inovet’s broad geographic footprint allows for targeted expansion strategies in emerging markets and underpenetrated regions with growing demand for veterinary pharmaceuticals.

Recent Product Launch The launch of the ATOP 7® spot-on demonstrates Inovet’s focus on innovative, high-demand animal health solutions, presenting sales opportunities around promotional efforts and expanded distribution channels in both existing and new markets.

Strategic Acquisition Inovet’s recent acquisition by Orion Corporation for over $128 million positions the company for increased investment in R&D and expansion, which can lead to new product lines and partnership opportunities with distributor networks seeking innovative veterinary solutions.

Production Capabilities With a modern manufacturing facility in France producing a wide array of pharmaceutical forms and offering toll manufacturing services, Inovet can support customized product needs and contract manufacturing opportunities to meet specific client demands.